Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden.
Dobilas A, Jansåker F, Li X, Sundquist K, Borgfeldt C.
BMC Cancer. 2023 Oct 9;23(1):951. doi: 10.1186/s12885-023-11453-6.
New definition of borderline resectable colorectal liver metastasis based on prognostic outcomes.
Chiba N, Iida S, Nakagawa M, Gunji T, Yokozuka K, Kobayashi T, Sano T, Shigoka M, Tabuchi S, Hidaka E, Kawachi S.
Langenbecks Arch Surg. 2024 Oct 8;409(1):301. doi: 10.1007/s00423-024-03492-9.
Circulating microRNAs as Early Biomarkers of Colon Cancer: A Nested Case-Control Study Within a Prospective Cohort.
Padroni L, Marmiroli G, De Marco L, Fiano V, Dansero L, Caini S, Masala G, Manfredi L, Milani L, Ricceri F, Sacerdote C.
Int J Mol Sci. 2025 Aug 15;26(16):7893. doi: 10.3390/ijms26167893.
Evolving role of gene expression signatures as biomarkers in early-stage colon cancer.
Goel G.
J Gastrointest Cancer. 2014 Dec;45(4):399-404. doi: 10.1007/s12029-014-9634-7.
Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination.
Nakamura E, Sato Y, Moriguchi S, Yamashita A, Higo T, Asada Y.
Case Rep Obstet Gynecol. 2015;2015:690891. doi: 10.1155/2015/690891. Epub 2015 May 13.
Mucin histochemistry of ovarian borderline tumors of mucinous and mixed-epithelial types.
Rutgers JL, Baergen RN.
Mod Pathol. 1994 Oct;7(8):825-8.
Ovarian Causes of Pseudomyxoma Peritonei (PMP)-A Literature Review.
Ionescu S, Marincas M, Madge OL, Dicu-Andreescu IG, Chitoran E, Rotaru V, Cirimbei C, Gherghe M, Ene A, Rosca R, Radu M, Simion L.
Cancers (Basel). 2024 Apr 9;16(8):1446. doi: 10.3390/cancers16081446.
Gastric epithelioid haemangioendothelioma.
Tavares AB, Almeida AG, Viveiros FA, Cidade CN, Barbosa JM.
BMJ Case Rep. 2011 May 10;2011:bcr0120113791. doi: 10.1136/bcr.01.2011.3791.
Colon cancer microsatellite instability influences computed tomography assessment of regional lymph node morphology and diagnostic performance.
Kim YT, Min JH, Choi KH, Kim H.
Eur J Radiol. 2022 Sep;154:110396. doi: 10.1016/j.ejrad.2022.110396. Epub 2022 Jun 11.
Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressiveness in colorectal cancer.
Hrudka J, Matěj R, Nikov A, Tomyak I, Fišerová H, Jelínková K, Waldauf P.
Sci Rep. 2022 Nov 9;12(1):19152. doi: 10.1038/s41598-022-22685-0.
